Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TYR | P14679 | 2/20 | 0.42 |
| ▸ | CA3 | P07451 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15932418 | 0.89 | ACHE (0.54) | ALOX15ALDH1A1LMNATYRCA3 | |
| SCHEMBL17369684 | 0.85 | LMNA (0.61) | ALOX15ALDH1A1LMNATYRCYP3A4 | |
| SCHEMBL10077999 | 0.84 | ESR2 (0.53) | ALDH1A1LMNACA14KDM4EMAPT | |
| SCHEMBL12601021 | 0.78 | LMNA (0.46) | ALDH1A1LMNACYP3A4HSD17B10KDM4E | |
| SCHEMBL15932386 | 0.77 | ACHE (0.45) | ALOX15ALDH1A1HSD17B10KDM4EMAPT | |
| SCHEMBL10045868 | 0.76 | KDM4E (0.41) | ALDH1A1LMNAHSD17B10KDM4EMAPT | |
| Hydroquinone SCHEMBL460669 | 0.65 | ALOX15 (1.00) | ALOX15ALDH1A1LMNATYRCA3 | |
| Hydroquinone SCHEMBL15516 | 0.65 | — | — | |
| Hydroquinone SCHEMBL11511669 | 0.65 | ALOX15 (1.00) | ALOX15ALDH1A1LMNATYRCA3 | |
| Hydroquinone SCHEMBL10550177 | 0.62 | CA3 (0.73) | ALOX15ALDH1A1LMNATYRCA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8114858-B2 | Derivatives of 4- or 5-aminosalicylic acid | ANTIBE THERAPEUTICS INC. (CA) | 2012-02-14 | — | — | US | disclosed |
| US-8114857-B2 | Derivatives of 4- or 5-aminosalicylic acid | ANTIBE THERAPEUTICS INC. (CA) | 2012-02-14 | — | — | US | disclosed |
| US-8114858-B2 | Derivatives of 4- or 5-aminosalicylic acid | ANTIBE THERAPEUTICS INC. (CA) | 2012-02-14 | — | — | US | disclosed |
| US-8114857-B2 | Derivatives of 4- or 5-aminosalicylic acid | ANTIBE THERAPEUTICS INC. (CA) | 2012-02-14 | — | — | US | disclosed |
| WO-2011082234-A1 | THIONATED AROMATIC BISIMIDES AS ORGANIC SEMICONDUCTORS AND DEVICES INCORPORATING THEM | POLYERA CORPORATION (US) | 2011-07-07 | — | — | WO | disclosed |
| EP-1883645-B1 | DERIVATIVES OF 4-OR 5-AMINOSALICYLIC ACID | ANTIBE THERAPEUTICS INC (CA) | 2011-06-29 | — | — | EP | disclosed |
| US-20110130368-A1 | DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID | ANTIBE THERAPEUTICS INC. (CA) | 2011-06-02 | — | — | US | disclosed |
| US-20110130368-A1 | DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID | ANTIBE THERAPEUTICS INC. (CA) | 2011-06-02 | — | — | US | disclosed |
| US-20110098257-A1 | DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID | ANTIBE THERAPEUTICS INC. (CA) | 2011-04-28 | — | — | US | disclosed |
| US-20110098257-A1 | DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID | ANTIBE THERAPEUTICS INC. (CA) | 2011-04-28 | — | — | US | disclosed |
| US-7498355-B2 | Derivatives of 4- or 5-aminosalicylic acid | ANTIBE THERAPEUTICS INC. (CA) | 2009-03-03 | — | — | US | disclosed |
| US-7488786-B2 | emulsion polymerization process for producing a polymer by controlled polymerization which comprises polymerizing at least one monomer in the presence of a free radical control agent | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2009-02-10 | — | — | US | disclosed |
| US-7462674-B2 | Oxathiazaphospholidine free radical control agent | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2008-12-09 | — | — | US | disclosed |
| US-20080207564-A1 | Derivaitves of 4-Or 5-Aminosalicylic Acid | ANTIBE THERAPEUTICS INC. (CA) | 2008-08-28 | — | — | US | disclosed |
| US-20080207564-A1 | Derivaitves of 4-Or 5-Aminosalicylic Acid | ANTIBE THERAPEUTICS INC. (CA) | 2008-08-28 | — | — | US | disclosed |
| US-20080097057-A1 | Oxathiazaphospholidine free radical control agent | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2008-04-24 | — | — | US | disclosed |
| US-7345186-B2 | Oxathiazaphospholidine free radical control agent | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2008-03-18 | — | — | US | disclosed |
| US-20080033197-A1 | Oxathiazaphospholidine free radical control agent | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2008-02-07 | — | — | US | disclosed |
| US-20070197479-A1 | Derivatives of 4- or 5-aminosalicylic acid | ANTIBE THERAPEUTICS INC. (CA) | 2007-08-23 | — | — | US | disclosed |
| US-20070197479-A1 | Derivatives of 4- or 5-aminosalicylic acid | ANTIBE THERAPEUTICS INC. (CA) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098257-A1 | DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID | CBS, SI, APC | ALOX15 98/4885ALDH1A1 572/4885LMNA 4653/4885 |
| US-20080207564-A1 | Derivaitves of 4-Or 5-Aminosalicylic Acid | CBS, SI, TST | ALOX15 203/4885ALDH1A1 388/4885LMNA 4721/4885 |
| US-20110130368-A1 | DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID | CBS, SI, APC | ALOX15 98/4885ALDH1A1 572/4885LMNA 4653/4885 |
| US-20080033197-A1 | Oxathiazaphospholidine free radical control agent | NOX4, AR, AHR | ALOX15 265/4885ALDH1A1 281/4885LMNA 1391/4885 |
| US-20070197479-A1 | Derivatives of 4- or 5-aminosalicylic acid | CBS, SI, APC | ALOX15 98/4885ALDH1A1 572/4885LMNA 4653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.